The CXCR4/CXCL12 axis is an interesting candidate for targeting the BM TME because of its important role in NB metastasis and progression and the contribution of MSCs to this signaling axis, as mentioned earlier in this review. This evidence concerns the gene CXCR4 and neuroblastoma.